97 related articles for article (PubMed ID: 9742557)
1. Development of a highly efficient purification process for recombinant adenoviral vectors for oral gene delivery.
Croyle MA; Anderson DJ; Roessler BJ; Amidon GL
Pharm Dev Technol; 1998 Aug; 3(3):365-72. PubMed ID: 9742557
[TBL] [Abstract][Full Text] [Related]
2. Purification of adenoviral vectors using expanded bed chromatography.
Peixoto C; Ferreira TB; Carrondo MJ; Cruz PE; Alves PM
J Virol Methods; 2006 Mar; 132(1-2):121-6. PubMed ID: 16266756
[TBL] [Abstract][Full Text] [Related]
3. Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography.
Eglon MN; Duffy AM; O'Brien T; Strappe PM
J Gene Med; 2009 Nov; 11(11):978-89. PubMed ID: 19670285
[TBL] [Abstract][Full Text] [Related]
4. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
Burova E; Ioffe E
Gene Ther; 2005 Oct; 12 Suppl 1():S5-17. PubMed ID: 16231055
[TBL] [Abstract][Full Text] [Related]
5. Purification of infectious adenovirus in two hours by ultracentrifugation and tangential flow filtration.
Ugai H; Yamasaki T; Hirose M; Inabe K; Kujime Y; Terashima M; Liu B; Tang H; Zhao M; Murata T; Kimura M; Pan J; Obata Y; Hamada H; Yokoyama KK
Biochem Biophys Res Commun; 2005 Jun; 331(4):1053-60. PubMed ID: 15882984
[TBL] [Abstract][Full Text] [Related]
6. Production of first generation adenoviral vectors for preclinical protocols: amplification, purification and functional titration.
Armendáriz-Borunda J; Bastidas-Ramírez BE; Sandoval-Rodríguez A; González-Cuevas J; Gómez-Meda B; García-Bañuelos J
J Biosci Bioeng; 2011 Nov; 112(5):415-21. PubMed ID: 21856222
[TBL] [Abstract][Full Text] [Related]
7. A new scalable method for the purification of recombinant adenovirus vectors.
Green AP; Huang JJ; Scott MO; Kierstead TD; Beaupré I; Gao GP; Wilson JM
Hum Gene Ther; 2002 Nov; 13(16):1921-34. PubMed ID: 12427304
[TBL] [Abstract][Full Text] [Related]
8. [Producing recombinant adenovirus encoding green fluorescent protein (Ad-GFP) by suspension cultured HEK-293 N3S cells].
Tian B; Wu B; Zhang QW; Bi JJ; Wang L; Zhu BZ; Geng Y; Wu ZZ
Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):915-8. PubMed ID: 18051875
[TBL] [Abstract][Full Text] [Related]
9. Development and optimization of an adenovirus production process.
Kamen A; Henry O
J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
[TBL] [Abstract][Full Text] [Related]
10. Improved purification of recombinant adenoviral vector by metal affinity membrane chromatography.
Lee DS; Kim BM; Seol DW
Biochem Biophys Res Commun; 2009 Jan; 378(3):640-4. PubMed ID: 19056351
[TBL] [Abstract][Full Text] [Related]
11. Localized adenovirus gene delivery using antiviral IgG complexation.
Levy RJ; Song C; Tallapragada S; DeFelice S; Hinson JT; Vyavahare N; Connolly J; Ryan K; Li Q
Gene Ther; 2001 May; 8(9):659-67. PubMed ID: 11406760
[TBL] [Abstract][Full Text] [Related]
12. Development of formulations that enhance physical stability of viral vectors for gene therapy.
Croyle MA; Cheng X; Wilson JM
Gene Ther; 2001 Sep; 8(17):1281-90. PubMed ID: 11571564
[TBL] [Abstract][Full Text] [Related]
13. Factors that influence stability of recombinant adenoviral preparations for human gene therapy.
Croyle MA; Roessler BJ; Davidson BL; Hilfinger JM; Amidon GL
Pharm Dev Technol; 1998 Aug; 3(3):373-83. PubMed ID: 9742558
[TBL] [Abstract][Full Text] [Related]
14. Towards purification of adenoviral vectors based on membrane technology.
Peixoto C; Ferreira TB; Sousa MF; Carrondo MJ; Alves PM
Biotechnol Prog; 2008; 24(6):1290-6. PubMed ID: 19194943
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral vectors for liver-directed gene therapy.
Connelly S
Curr Opin Mol Ther; 1999 Oct; 1(5):565-72. PubMed ID: 11249663
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral vectors: production and purification.
Albayya FP; Metzger JM
Methods Mol Biol; 2003; 219():3-17. PubMed ID: 12596995
[No Abstract] [Full Text] [Related]
17. Stability of adenoviral vectors following catheter delivery.
Tsui LV; Zayek N; Frey D; Mello C; Banik G; Falotico R; McArthur JG
Mol Ther; 2001 Jan; 3(1):122-5. PubMed ID: 11162319
[TBL] [Abstract][Full Text] [Related]
18. Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A.
Zhang WW; Josephs SF; Zhou J; Fang X; Alemany R; Balagué C; Dai Y; Ayares D; Prokopenko E; Lou YC; Sethi E; Hubert-Leslie D; Kennedy M; Ruiz L; Rockow-Magnone S
Thromb Haemost; 1999 Aug; 82(2):562-71. PubMed ID: 10605752
[TBL] [Abstract][Full Text] [Related]
19. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR.
Zhang WW; Koch PE; Roth JA
Biotechniques; 1995 Mar; 18(3):444-7. PubMed ID: 7779393
[TBL] [Abstract][Full Text] [Related]
20. Production of lentiviral vectors by transient expression of minimal packaging genes from recombinant adenoviruses.
Kuate S; Stefanou D; Hoffmann D; Wildner O; Uberla K
J Gene Med; 2004 Nov; 6(11):1197-205. PubMed ID: 15459964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
